Skip Navigation


European Heart Journal Advance Access originally published online on November 1, 2007
European Heart Journal 2007 28(24):3020-3026; doi:10.1093/eurheartj/ehm454
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
28/24/3020    most recent
ehm454v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Weidemann, F.
Right arrow Articles by Strotmann, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weidemann, F.
Right arrow Articles by Strotmann, J. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org

A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium

Frank Weidemann1,*,{dagger}, Markus Niemann1,{dagger}, Sebastian Herrmann1, Margret Kung1, Stefan Störk1, Christiane Waller1, Meinrad Beer2, Frank Breunig1, Christoph Wanner1, Wolfram Voelker1, Georg Ertl1, Bart Bijnens3,4 and Joerg M. Strotmann1

1 Department of Medicine I/Center of Cardiovascular Medicine, Würzburg, Germany
2 Department of Radiology, University Hospital Würzburg, Würzburg, Germany
3 Department of Cardiology, St. Georges Hospital, London, UK
4 KU Leuven, Leuven, Belgium

Received 18 May 2007; revised 30 August 2007; accepted 13 September 2007; online publish-ahead-of-print 1 November 2007.

* Corresponding author: Medizinische Klinik und Poliklinik I, Herz- und Kreislaufzentrum der Universität Würzburg, Josef-Schneider Str. 2, D 20, 97080 Wuerzburg, Germany. Tel: +49 931 2010; fax: +49 931 20136291. E-mail address: weidemann_f{at}medizin.uni-wuerzburg.de

Aims: Regional myocardial fibrosis detected by magnetic resonance imaging (MRI) using late enhancement (LE) indicates an unfavorable prognosis. We investigated in a prospective study whether regional non-ischaemic fibrosis in hypertrophic myocardium can also be detected by ultrasonic strain-rate imaging based on specific visual features of the myocardial deformation traces.

Methods and results: This diagnostic study aimed to define left ventricular fibrotic segments in 30 patients with hypertrophic cardiomyopathy (n = 10), severe aortic valve stenosis (n = 10), Fabry disease cardiomyopathy (n = 10), and 10 healthy controls. MRI and strain-rate imaging (=deformation imaging) was performed in all patients and controls to detect LE. In total, 42 segments showed LE according to MRI criteria. Using strain-rate imaging, all LE positive segments displayed a characteristic pattern consisting of a first peak in early systole followed by a rapid fall in strain rate close to zero and a second peak during isovolumetric relaxation. This ‘double peak sign’ was never seen in segments of healthy controls. However, it was detected in 10 segments without LE. These ‘false-positive’ segments belonged to Fabry patients who often develop a fast progressing fibrosis. In a follow-up MRI study after 2 years (available for 6/10 segments), all these segments had developed LE.

Conclusion: The ‘double peak sign’ in strain-rate imaging tracings seems to be a reliable tool to diagnose regional fibrosis.

Key Words: Fibrosis • Late enhancement • Strain rate • Myocardial function


{dagger} The first two authors contributed equally to this work.

This paper was guest edited by Prof. Thierry Gillebert, Department of Cardiovascular Medicine, University of Gent, Gent, Belgium


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
F. Weidemann, S. Herrmann, S. Stork, M. Niemann, S. Frantz, V. Lange, M. Beer, S. Gattenlohner, W. Voelker, G. Ertl, et al.
Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis
Circulation, August 18, 2009; 120(7): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Weidemann, M. Niemann, F. Breunig, S. Herrmann, M. Beer, S. Stork, W. Voelker, G. Ertl, C. Wanner, and J. Strotmann
Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy: Evidence for a Better Outcome With Early Treatment
Circulation, February 3, 2009; 119(4): 524 - 529.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
T. Kovacevic-Preradovic, M. Zuber, C.H. A. Jost, U. Widmer, B. Seifert, G. Schulthess, A. Fischer, and R. Jenni
Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy
Eur J Echocardiogr, November 1, 2008; 9(6): 729 - 735.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.